Fenbendazole success story for a patient sent home to die from Esophageal Cancer (by Daylene Martinez Oct.2023)




According to Dr William Makis (source):

Patient: 93 year old man with esophageal cancer (distal esophagus), sent home on hospice to die.

Her dad took 3ml (300mg) of Safeguard (Merck) Fenbendazole once a day, 3 days on 4 days off, from July 30, 2023 until Oct.10, 2023 when he was declared cancer free on follow-up scans.

That’s 2.5 months on what would be considered a fairly low dose of Fenbendazole.

The liquid may absorb better than pills or powder.

Comments

Labels

Show more

Archive

Show more

Popular posts from this blog

Ivermectin and Fenbendazole: Treating Turbo Cancer - Dr William Makis

Fenbendazole Joe Tippens Protocol: A Step-by-Step Guide (2024)

Fenbendazole Cancer Success Stories: 107 Case Reports Compilation (February 2025 Edition)

Ivermectin, Fenbendazole and Mebendazole in Cancer: 2024 Peer-Reviewed Protocol in Cancer

Fenbendazole: Side Effects, Safety and Dosage in Humans (2025)

Fenbendazole: Questions Answered, Things to Know, Useful Tips - Ben Fen

FENBENDAZOLE and CANCER: 15 Minutes with Dr. William Makis

Exploring the Anticancer Potential of Fenbendazole: A Review of Anecdotal Case Reports and Emerging Evidence (2025)

12 Types of Zinc Supplementation and Absorption 2025

Fenbendazole vs Mebendazole for Cancer: What is the Difference?